These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
233 related items for PubMed ID: 36346503
1. Dosimetry estimation and preliminary clinical application of [99mTc]Tc-HYNIC-PSMA-XL-2 in prostate cancer. Yang H, Gao Z, Xu X, Liu C, Hu S, Zhang J, Song S. Ann Nucl Med; 2023 Jan; 37(1):60-69. PubMed ID: 36346503 [Abstract] [Full Text] [Related]
2. Evaluation of Radiation dosimetry of 99mTc-HYNIC-PSMA and imaging in prostate cancer. Zhang J, Zhang J, Xu X, Lu L, Hu S, Liu C, Cheng J, Song S, Zhang Y, Shi LQ. Sci Rep; 2020 Mar 06; 10(1):4179. PubMed ID: 32144340 [Abstract] [Full Text] [Related]
3. Radiation Dosimetry of 99mTc-PSMA I&S: A Single-Center Prospective Study. Urbán S, Meyer C, Dahlbom M, Farkas I, Sipka G, Besenyi Z, Czernin J, Calais J, Pávics L. J Nucl Med; 2021 Aug 01; 62(8):1075-1081. PubMed ID: 33277398 [Abstract] [Full Text] [Related]
4. More advantages in detecting bone and soft tissue metastases from prostate cancer using 18F-PSMA PET/CT. Pianou NK, Stavrou PZ, Vlontzou E, Rondogianni P, Exarhos DN, Datseris IE. Hell J Nucl Med; 2019 Aug 01; 22(1):6-9. PubMed ID: 30843003 [Abstract] [Full Text] [Related]
5. Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT. Lawal IO, Ankrah AO, Mokgoro NP, Vorster M, Maes A, Sathekge MM. Prostate; 2017 Aug 01; 77(11):1205-1212. PubMed ID: 28649735 [Abstract] [Full Text] [Related]
6. [99mTc]Tc-HYNIC-ALUG SPECT/CT in the initial staging of 227 consecutive patients with newly diagnosed prostate cancer: a 5-year monocentric retrospective study. Li B, Ding X, Duan L, Shi J, Tang M, Zhang J, Zhao Z, Wu X, Gao Y. Front Endocrinol (Lausanne); 2024 Aug 01; 15():1326858. PubMed ID: 38449842 [Abstract] [Full Text] [Related]
7. 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients. Santos-Cuevas C, Davanzo J, Ferro-Flores G, García-Pérez FO, Ocampo-García B, Ignacio-Alvarez E, Gómez-Argumosa E, Pedraza-López M. Nucl Med Biol; 2017 Sep 01; 52():1-6. PubMed ID: 28575794 [Abstract] [Full Text] [Related]
8. Preclinical Evaluation and First Patient Application of 99mTc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer. Robu S, Schottelius M, Eiber M, Maurer T, Gschwend J, Schwaiger M, Wester HJ. J Nucl Med; 2017 Feb 01; 58(2):235-242. PubMed ID: 27635024 [Abstract] [Full Text] [Related]
9. Relationship between PSA kinetics and Tc-99m HYNIC PSMA SPECT/CT detection rates of biochemical recurrence in patients with prostate cancer after radical prostatectomy. Liu C, Zhu Y, Su H, Xu X, Zhang Y, Ye D, Hu S. Prostate; 2018 Dec 01; 78(16):1215-1221. PubMed ID: 30027591 [Abstract] [Full Text] [Related]
10. Clinical translation of a PSMA inhibitor for 99mTc-based SPECT. Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Orocio-Rodríguez E, Davanzo J, García-Pérez FO. Nucl Med Biol; 2017 May 01; 48():36-44. PubMed ID: 28193503 [Abstract] [Full Text] [Related]
11. SPECT-CT Imaging with [99mTc]PSMA-T4 in patients with Recurrent Prostate Cancer. Sergieva S, Mangaldgiev R, Dimcheva M, Nedev K, Zahariev Z, Robev B. Nucl Med Rev Cent East Eur; 2021 May 01; 24(2):70-81. PubMed ID: 34382671 [Abstract] [Full Text] [Related]
12. Head-to-head comparison of 99mTc-PSMA and 99mTc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial. Zhang Y, Lin Z, Li T, Wei Y, Yu M, Ye L, Cai Y, Yang S, Zhang Y, Shi Y, Chen W. Sci Rep; 2022 Sep 26; 12(1):15993. PubMed ID: 36163353 [Abstract] [Full Text] [Related]
13. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging. Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V. Nucl Med Commun; 2014 Apr 26; 35(4):423-32. PubMed ID: 24335877 [Abstract] [Full Text] [Related]
14. Synthesis and Evaluation of 99mTc-Labeled PSMA-Targeted Tracers Based on the Lys-Urea-Aad Pharmacophore for Detecting Prostate Cancer with Single Photon Emission Computed Tomography. Lu K, Zhang C, Zhang Z, Kuo HT, Colpo N, Bénard F, Lin KS. Molecules; 2023 Jun 29; 28(13):. PubMed ID: 37446782 [Abstract] [Full Text] [Related]
15. The efficacy of 99mTc-HYNIC-PSMA SPECT/CT in detecting primary lesions and metastasis in newly diagnosed prostate cancer. Wang T, Zhao L, Qiao W, Sun N, Zhao J, Xing Y. Front Oncol; 2023 Jun 29; 13():1165694. PubMed ID: 37333816 [Abstract] [Full Text] [Related]
16. PSMA SPECT/CT with 99mTc-MIP-1404 in biochemical recurrence of prostate cancer: predictive factors and efficacy for the detection of PSMA-positive lesions at low and very-low PSA levels. Schmidkonz C, Goetz TI, Kuwert T, Ritt P, Prante O, Bäuerle T, Goebell P, Cordes M. Ann Nucl Med; 2019 Dec 29; 33(12):891-898. PubMed ID: 31502084 [Abstract] [Full Text] [Related]
17. Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality. Singh B, Sharma S, Bansal P, Hooda M, Singh H, Parihar AS, Kumar A, Watts A, Mohan R, Singh SK. Nucl Med Commun; 2021 May 01; 42(5):482-489. PubMed ID: 33395191 [Abstract] [Full Text] [Related]
18. 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer. Schmidkonz C, Hollweg C, Beck M, Reinfelder J, Goetz TI, Sanders JC, Schmidt D, Prante O, Bäuerle T, Cavallaro A, Uder M, Wullich B, Goebell P, Kuwert T, Ritt P. Prostate; 2018 Jan 01; 78(1):54-63. PubMed ID: 29105797 [Abstract] [Full Text] [Related]
19. Delayed Imaging Improves Lesion Detectability in [99mTc]Tc-PSMA-I&S SPECT/CT in Recurrent Prostate Cancer. Berliner C, Steinhelfer L, Chantadisai M, Kroenke M, Koehler D, Pose R, Bannas P, Knipper S, Eiber M, Maurer T. J Nucl Med; 2023 Jul 01; 64(7):1036-1042. PubMed ID: 37230531 [Abstract] [Full Text] [Related]
20. 99mTc-PSMA targeted robot-assisted radioguided surgery during radical prostatectomy and extended lymph node dissection of prostate cancer patients. Yılmaz B, Şahin S, Ergül N, Çolakoğlu Y, Baytekin HF, Sökmen D, Tuğcu V, Taşçı Aİ, Çermik TF. Ann Nucl Med; 2022 Jul 01; 36(7):597-609. PubMed ID: 35426599 [Abstract] [Full Text] [Related] Page: [Next] [New Search]